Braze, Inc. BRZE
45.97 USD +0.18 (+0.38%)
Nov 4, 2026, 2:11 PM EST
45.77 Day range 45.99
15.79 52-week range 45.97
- YTD
- +34.05%
- 1 year
- +68.86%
Analyst view
Consensus: hold
Hold
Price target (mean) 47.54 +3.4% upside
Now 45.97
- Target (low)
- 47.50
- Target (mean)
- 47.54
- Target (high)
- 48.00
Ratings (0m) 19 0 buy · 19 hold · 0 sell
- Strong buy0
- Buy0
- Hold19
- Sell0
- Strong sell0
Recommendation trend
- This month 19
- 1 month ago 21
- 2 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.14004 | 0.13 – 0.15274 | 0.06 | +133.4% | 229.88M | +20.4% | 20 |
| Next quarter | 0.21503 | 0.19 – 0.2231 | 0.10 | +115.0% | 244.25M | +19.0% | 20 |
| Current year | 0.64251 | 0.63 – 0.67284 | 0.38 | +69.1% | 912.38M | +23.6% | 20 |
| Next year | 0.98195 | 0.808 – 1.14 | 0.64251 | +52.8% | 1.07B | +17.0% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Oct 21, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Oct 21, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 21, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Oct 21, 2026 | DA Davidson | Downgrade | Buy | Neutral |
| Oct 21, 2026 | Raymond James | Downgrade | Outperform | Market Perform |
| Oct 21, 2026 | BTIG | Downgrade | Buy | Neutral |
| Oct 20, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Oct 20, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| Oct 20, 2026 | Stifel | Downgrade | Buy | Hold |
| Oct 20, 2026 | Piper Sandler | Downgrade | Overweight | Neutral |
| Oct 5, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Oct 1, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 30, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 9, 2026 | DA Davidson | Maintained | Buy | Buy |
| Sep 9, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 9, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 9, 2026 | Raymond James | Maintained | Outperform | Outperform |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Sep 9, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Sep 9, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Sep 9, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 9, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Sep 2, 2026 | DA Davidson | Maintained | Buy | Buy |
| Sep 2, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 27, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 14, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
